Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prophase Labs Inc PRPH

ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its... see more

Recent & Breaking News (NDAQ:PRPH)

ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures

GlobeNewswire December 11, 2024

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

GlobeNewswire November 19, 2024

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024

GlobeNewswire November 13, 2024

ProPhase Labs Announces Closing of Public Offering of Common Stock

GlobeNewswire November 12, 2024

ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024

GlobeNewswire November 11, 2024

ProPhase Labs Announces Pricing of Public Offering of Common Stock

GlobeNewswire November 7, 2024

ProPhase Labs Announces Proposed Public Offering of Common Stock

GlobeNewswire November 7, 2024

ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry

GlobeNewswire November 4, 2024

ProPhase Labs to Present at the 2024 ThinkEquity Conference

GlobeNewswire October 22, 2024

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

GlobeNewswire October 17, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Accesswire September 11, 2024

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

GlobeNewswire August 19, 2024

ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024

GlobeNewswire August 14, 2024

ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test

GlobeNewswire August 13, 2024

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

GlobeNewswire August 7, 2024

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

GlobeNewswire July 11, 2024

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

GlobeNewswire May 9, 2024

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.

GlobeNewswire May 9, 2024

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9

GlobeNewswire May 2, 2024

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

GlobeNewswire April 25, 2024